Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
astrazeneca
3
×
biotech
boston blog main
3
×
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
clinical trials
detroit blog main
detroit top stories
eli lilly
3
×
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
avexis
biogen
cancer
cancer immunotherapy
celgene
drugs
What
bio
roundup
biotech
drug
fda
news
alzheimer’s
annual
approved
assessed
attention
august
busy
communities
companies
conference
days
decisions
devices
digital
disease
drugs
epidemic
esmo
europe
fatty
frenzied
germany
growing
hosted
investment
known
led
legacy
liver
merck
munich
nash
nods
opioid
Language
unset
Current search:
astrazeneca
×
" boston blog main "
×
" bristol-myers squibb "
×
" eli lilly "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More